Microvascular Tissue Oximetry
Value Proposition
Resonance Raman Spectroscopy (RSS) is resistant to interference and provides a precise, quantitative chemical fingerprint of how well tissues are being oxygenated, without the need for a central venous catheter. Using RSS in this device allows the sensor to be placed in the mouth and provide oxygenation information in seconds.
Competitive Advantage
The sensor can be placed in the mouth and provide oxygenation information in seconds, allowing for continuous monitoring or intermittent screening.
Unique Features
Continuous Monitoring
Less Invasive
Quick Results
Licensing Information
Pendar Technologies in 2018
Principal Investigators
Kevin Ward, MD
Hakam Tiba, MD, MS
Kyle Gunnerson, MD
Intellectual Property
Patent Issued # US7113814
Solution Sheet
Download Solution Sheet (PDF)
Image courtesy of project team
Because of its non-invasive nature, RSS may serve as a faster, safer, and more cost-effective way to assess patient tissue oxygenation, aiding in the diagnosis and treatment of conditions such as sepsis, trauma, heart failure, and other critical states.
Contact Pendar Technologies for more information about investment and partnership opportunities.
Funding History
$2,999,754 in non-dilutive funding
2018 $2,999,754 DOD
Substantial departmental, school and center based support
Funding Organizations
Publications
This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs through the JPC-6 Combat Casualty Care / Defense Medical Research and Development Program under an assistance agreement from the U.S. Army Medical Research Activity, Award No. W81XWH-18-1-0078.